Cubist Systematic Strategies LLC Buys Shares of 6,610 U.S. Physical Therapy, Inc. (NYSE:USPH)

Cubist Systematic Strategies LLC purchased a new stake in U.S. Physical Therapy, Inc. (NYSE:USPH - Free Report) in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund purchased 6,610 shares of the company's stock, valued at approximately $586,000.

A number of other large investors have also bought and sold shares of the business. HighTower Advisors LLC boosted its stake in shares of U.S. Physical Therapy by 2.5% during the 4th quarter. HighTower Advisors LLC now owns 4,833 shares of the company's stock worth $429,000 after acquiring an additional 119 shares during the period. CBIZ Investment Advisory Services LLC boosted its position in U.S. Physical Therapy by 59.8% during the fourth quarter. CBIZ Investment Advisory Services LLC now owns 326 shares of the company's stock worth $29,000 after purchasing an additional 122 shares during the period. Albert D Mason Inc. boosted its position in U.S. Physical Therapy by 1.3% during the fourth quarter. Albert D Mason Inc. now owns 10,596 shares of the company's stock worth $940,000 after purchasing an additional 139 shares during the period. Aquatic Capital Management LLC increased its holdings in shares of U.S. Physical Therapy by 18.0% in the fourth quarter. Aquatic Capital Management LLC now owns 1,298 shares of the company's stock valued at $115,000 after purchasing an additional 198 shares during the last quarter. Finally, Norden Group LLC raised its position in shares of U.S. Physical Therapy by 4.8% in the fourth quarter. Norden Group LLC now owns 5,139 shares of the company's stock valued at $456,000 after purchasing an additional 235 shares during the period.

Analyst Ratings Changes

Several research analysts have weighed in on the stock. JMP Securities reissued a "market outperform" rating and issued a $113.00 price target on shares of U.S. Physical Therapy in a report on Tuesday, April 22nd. Barrington Research lowered their target price on U.S. Physical Therapy from $108.00 to $98.00 and set an "outperform" rating on the stock in a research note on Friday, February 28th. William Blair reissued a "market perform" rating on shares of U.S. Physical Therapy in a report on Thursday, February 27th. JPMorgan Chase & Co. decreased their price objective on U.S. Physical Therapy from $120.00 to $110.00 and set an "overweight" rating on the stock in a report on Wednesday, March 19th. Finally, StockNews.com upgraded U.S. Physical Therapy from a "sell" rating to a "hold" rating in a research report on Thursday, May 8th. Two investment analysts have rated the stock with a hold rating, four have assigned a buy rating and one has given a strong buy rating to the company's stock. According to data from MarketBeat.com, the stock presently has a consensus rating of "Moderate Buy" and a consensus target price of $109.00.

U.S. Physical Therapy Price Performance

NYSE:USPH traded down $1.14 during trading hours on Wednesday, reaching $78.27. 6,134 shares of the company were exchanged, compared to its average volume of 110,458. The company has a market capitalization of $1.19 billion, a P/E ratio of 83.28, a P/E/G ratio of 3.54 and a beta of 1.44. The company has a debt-to-equity ratio of 0.27, a current ratio of 1.78 and a quick ratio of 1.78. The business has a 50 day moving average of $71.94 and a 200 day moving average of $83.53. U.S. Physical Therapy, Inc. has a 1-year low of $62.77 and a 1-year high of $106.06.

U.S. Physical Therapy (NYSE:USPH - Get Free Report) last issued its quarterly earnings results on Wednesday, May 7th. The company reported $0.48 EPS for the quarter, topping analysts' consensus estimates of $0.46 by $0.02. U.S. Physical Therapy had a return on equity of 8.11% and a net margin of 3.54%. The company had revenue of $183.79 million for the quarter, compared to analysts' expectations of $176.78 million. During the same quarter last year, the business earned $0.51 earnings per share. U.S. Physical Therapy's revenue was up 18.0% on a year-over-year basis. Research analysts forecast that U.S. Physical Therapy, Inc. will post 2.67 EPS for the current year.

U.S. Physical Therapy Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Friday, June 13th. Stockholders of record on Friday, May 23rd will be issued a dividend of $0.45 per share. This represents a $1.80 dividend on an annualized basis and a dividend yield of 2.30%. The ex-dividend date of this dividend is Friday, May 23rd. U.S. Physical Therapy's dividend payout ratio (DPR) is presently 82.57%.

Insider Buying and Selling

In related news, COO Graham D. Reeve sold 1,730 shares of the firm's stock in a transaction dated Friday, March 7th. The stock was sold at an average price of $82.11, for a total value of $142,050.30. Following the sale, the chief operating officer now directly owns 7,168 shares of the company's stock, valued at $588,564.48. This trade represents a 19.44% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available through this link. 2.00% of the stock is currently owned by company insiders.

U.S. Physical Therapy Company Profile

U.S. Physical Therapy, Inc operates outpatient physical therapy clinics. The company operates through Physical Therapy Operations and Industrial Injury Prevention Services segments. The company provides pre-and post-operative care and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers, and neurological-related injuries.